Baillie Gifford & CO Adaptimmune Therapeutics PLC Transaction History

Baillie Gifford & CO

  • $127 Billion
  • Q4 2024

A detailed history of Baillie Gifford & CO transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Baillie Gifford & CO holds 11,819,095 shares of ADAP stock, worth $6.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,819,095
Previous 16,775,860 29.55%
Holding current value
$6.62 Million
Previous $15.9 Million 59.95%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025
SELL
$0.54 - $0.95 $2.68 Million - $4.71 Million
-4,956,765 Reduced 29.55%
11,819,095 $6.38 Million
Q3 2024

Nov 05, 2024
BUY
$0.92 - $1.39 $1.5 Million - $2.26 Million
1,626,657 Added 10.74%
16,775,860 $15.9 Million
Q2 2024

Jul 25, 2024
SELL
$0.83 - $1.47 $599,817 - $1.06 Million
-722,672 Reduced 4.55%
15,149,203 $14.8 Million
Q1 2024

May 01, 2024
SELL
$0.7 - $1.75 $28,185 - $70,463
-40,265 Reduced 0.25%
15,871,875 $25.1 Million
Q4 2023

Jan 26, 2024
SELL
$0.43 - $0.79 $531,165 - $975,862
-1,235,269 Reduced 7.2%
15,912,140 $12.6 Million
Q3 2023

Nov 13, 2023
SELL
$0.73 - $1.04 $20,969 - $29,875
-28,726 Reduced 0.17%
17,147,409 $13.4 Million
Q2 2023

Jul 28, 2023
BUY
$0.9 - $1.51 $57,719 - $96,840
64,133 Added 0.37%
17,176,135 $15.8 Million
Q1 2023

May 03, 2023
SELL
$1.06 - $2.16 $61,413 - $125,143
-57,937 Reduced 0.34%
17,112,002 $18.7 Million
Q4 2022

Jan 24, 2023
BUY
$1.05 - $2.53 $2.63 Million - $6.34 Million
2,505,003 Added 17.08%
17,169,939 $25.1 Million
Q3 2022

Oct 27, 2022
SELL
$1.06 - $2.41 $695,794 - $1.58 Million
-656,410 Reduced 4.28%
14,664,936 $15.8 Million
Q2 2022

Aug 08, 2022
SELL
$1.33 - $2.28 $78,725 - $134,957
-59,192 Reduced 0.38%
15,321,346 $26 Million
Q1 2022

May 05, 2022
BUY
$1.73 - $4.06 $2.81 Million - $6.59 Million
1,624,186 Added 11.81%
15,380,538 $31.7 Million
Q4 2021

Jan 20, 2022
BUY
$3.5 - $5.68 $3.26 Million - $5.29 Million
931,372 Added 7.26%
13,756,352 $51.6 Million
Q3 2021

Oct 19, 2021
BUY
$3.44 - $6.37 $3.88 Million - $7.19 Million
1,128,061 Added 9.64%
12,824,980 $66.3 Million
Q2 2021

Aug 02, 2021
BUY
$3.86 - $5.78 $885,491 - $1.33 Million
229,402 Added 2.0%
11,696,919 $49.8 Million
Q1 2021

May 06, 2021
BUY
$4.9 - $6.83 $5.44 Million - $7.58 Million
1,109,737 Added 10.71%
11,467,517 $60.9 Million
Q4 2020

Feb 10, 2021
BUY
$4.0 - $9.2 $13.1 Million - $30.2 Million
3,279,717 Added 46.34%
10,357,780 $55.8 Million
Q3 2020

Nov 12, 2020
BUY
$7.66 - $10.78 $13.7 Million - $19.3 Million
1,788,394 Added 33.81%
7,078,063 $56.5 Million
Q2 2020

Aug 12, 2020
BUY
$2.58 - $12.1 $2.41 Million - $11.3 Million
935,646 Added 21.49%
5,289,669 $53 Million
Q1 2020

May 08, 2020
BUY
$1.2 - $4.52 $79,773 - $300,480
66,478 Added 1.55%
4,354,023 $11.8 Million
Q4 2019

Feb 10, 2020
BUY
$0.72 - $1.43 $88,371 - $175,515
122,738 Added 2.95%
4,287,545 $5.15 Million
Q3 2019

Nov 07, 2019
BUY
$1.43 - $3.81 $29,982 - $79,884
20,967 Added 0.51%
4,164,807 $6.29 Million
Q2 2019

Aug 08, 2019
BUY
$3.23 - $5.41 $984,019 - $1.65 Million
304,650 Added 7.94%
4,143,840 $16.7 Million
Q1 2019

May 01, 2019
BUY
$3.63 - $6.06 $506,998 - $846,394
139,669 Added 3.78%
3,839,190 $0
Q4 2018

Feb 14, 2019
BUY
$3.76 - $14.16 $1.06 Million - $3.99 Million
281,894 Added 8.25%
3,699,521 $21.3 Million
Q3 2018

Nov 13, 2018
BUY
$8.27 - $13.56 $3.18 Million - $5.21 Million
384,366 Added 12.67%
3,417,627 $46.3 Million
Q2 2018

Jul 17, 2018
BUY
$10.42 - $13.74 $4.88 Million - $6.43 Million
467,852 Added 18.24%
3,033,261 $36 Million
Q1 2018

May 10, 2018
BUY
$7.1 - $11.56 $4.58 Million - $7.45 Million
644,816 Added 33.57%
2,565,409 $28.8 Million
Q4 2017

Feb 13, 2018
BUY
$6.68 - $8.74 $3.62 Million - $4.73 Million
541,289 Added 39.24%
1,920,593 $12.8 Million
Q3 2017

Oct 20, 2017
BUY
$4.93 - $8.93 $276,060 - $500,044
55,996 Added 4.23%
1,379,304 $11.3 Million
Q2 2017

Aug 10, 2017
BUY
N/A
1,323,308
1,323,308 $5.94 Million

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
123M
Call Options Held
34.2K
Put Options Held
16.3K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $91.5M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email